Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control

(MedPage Today) -- LOUISVILLE, Ky. -- Tumor outcomes and thrombus control in renal cell carcinoma (RCC) improved with perioperative treatment that included a targeted agent plus immunotherapy, a small retrospective analysis showed.
Immuno-oncology...